Bagaan, Cherry S.
HRN: 26-24-93 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/20/2024
LEVOFLOXACIN 500MG (TAB)
11/20/2024
11/25/2024
ORAL
1/2 Tab
OD
Sepsis , CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes